TELA Dividend: TELA Bio Inc Yield Insights

Income

Balance sheet

Cash flow

Annual

Quarterly

TELA Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	75	69	58	41	29	18
Revenue Growth (YoY)	17%	19%	41%	41%	61%	20%
Cost of Revenue	24	22	18	14	10	6
Gross Profit	50	46	40	27	18	11
Selling, General & Admin	78	79	74	57	41	32
Research & Development	8	8	9	8	6	4
Operating Expenses	87	88	84	66	48	36
Other Non Operating Income (Expenses)	1	1	2	0	0	0
Pretax Income	-40	-37	-46	-44	-33	-28
Income Tax Expense	0	0	--	--	--	--
Net Income	-40	-37	-46	-44	-33	-28
Net Income Growth	-5%	-20%	5%	33%	18%	-7%
Shares Outstanding (Diluted)	45.36	28.52	22.86	16.27	14.47	12.93
Shares Change (YoY)	81%	25%	41%	12%	12%	13%
EPS (Diluted)	-0.89	-1.32	-2.04	-2.72	-2.3	-2.23
EPS Growth	-48%	-35%	-25%	18%	3%	-16%
Free Cash Flow	-34	-42	-41	-42	-31	-24
Free Cash Flow Per Share	-0.74	-1.47	-1.79	-2.58	-2.14	-1.85
Gross Margin	66.66%	66.66%	68.96%	65.85%	62.06%	61.11%
Operating Margin	-49.33%	-59.42%	-75.86%	-95.12%	-100%	-138.88%
Profit Margin	-53.33%	-53.62%	-79.31%	-107.31%	-113.79%	-155.55%
Free Cash Flow Margin	-45.33%	-60.86%	-70.68%	-102.43%	-106.89%	-133.33%
EBITDA	-36	-40	-44	-38	-29	-25
EBITDA Margin	-48%	-57.97%	-75.86%	-92.68%	-100%	-138.88%
D&A For EBITDA	1	1	0	1	0	0
EBIT	-37	-41	-44	-39	-29	-25
EBIT Margin	-49.33%	-59.42%	-75.86%	-95.12%	-100%	-138.88%
Effective Tax Rate	0%	0%	--	--	--	--